Where does OrsoBio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across OrsoBio's 2 recorded funding rounds.

Premier Alternatives

OrsoBio

Menlo Park, CA · Founded 2020 · Privately Held (backing)

Operator of a clinical-stage biopharmaceutical company intended to develop therapies for organ dysfunction. OrsoBio is based in Menlo Park, CA and was founded in 2020. Its last known valuation is $310 million. It has raised $167 million across 2 recorded rounds; the latest was a $40 million early-stage round in Aug 2024.

Last price · $/share

—

Implied valuation

$310.0M

Total raised

$166.6M

Last round

Early Stage VC

Aug 2024

Cap table — not yet on record

OrsoBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of OrsoBio with a free account

·Watch OrsoBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about OrsoBio

Where does OrsoBio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across OrsoBio's 2 recorded funding rounds.